Distinct Structural TCR Repertoires in Naturally Occurring Versus Vaccine-Induced CD8+ T-Cell Responses to the Tumor-Specific Antigen NY-ESO-1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Distinct Structural TCR Repertoires in Naturally Occurring Versus Vaccine-Induced CD8+ T-Cell Responses to the Tumor-Specific Antigen NY-ESO-1

Published:2005-05 Issue:3 Volume:28 Page:252-257
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Le Gal Frédérique-Anne,Ayyoub Maha,Dutoit Valérie,Widmer Valérie,Jäger Elke,Cerottini Jean-Charles,Dietrich Pierre-Yves,Valmori Danila

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference16 articles.

1. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.;Scanlan;Immunol Rev,2002

2. Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters.;Gotter;J Exp Med,2004

3. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.;Jager;J Exp Med,1998

4. Naturally occurring HLA-A2 restricted CD8+ T cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.;Valmori;Cancer Res,2000

5. Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting.;Dutoit;J Clin Invest,2002

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy;Clinical and Translational Medicine;2024-09

2. Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment;Frontiers in Immunology;2023-09-05

3. Infectious Agents and Bone Marrow Failure: A Causal or a Casual Connection?;Frontiers in Medicine;2021-11-04

4. STARTRAC analyses of scRNAseq data from tumor models reveal T cell dynamics and therapeutic targets;Journal of Experimental Medicine;2021-04-26

5. Identification of NY-ESO-1157–165 Specific Murine T Cell Receptors With Distinct Recognition Pattern for Tumor Immunotherapy;Frontiers in Immunology;2021-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3